VON ESCHENBACH ANDREW C. 4
4 · Celularity Inc · Filed Dec 2, 2021
Insider Transaction Report
Form 4
Celularity IncCELU
VON ESCHENBACH ANDREW C.
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2021-11-09$0.28/sh+100,000$28,000→ 100,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-11-09−100,000→ 207,437 totalExercise: $0.28Exp: 2027-06-02→ Class A Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option is fully vested and exercisable.